Korro Bio Inc KRRO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:25 AM EDT
61.88quote price arrow up+0.89 (+1.47%)
Volume
3,221
52 week range
9.15 - 97.91
Loading...
  • Open62.00
  • Day High62.00
  • Day Low60.87
  • Prev Close60.99
  • 52 Week High97.91
  • 52 Week High Date03/27/24
  • 52 Week Low9.15
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap573.84M
  • Shares Out9.27M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta2.28
  • YTD % Change27

KEY STATS

  • Open62.00
  • Day High62.00
  • Day Low60.87
  • Prev Close60.99
  • 52 Week High97.91
  • 52 Week High Date03/27/24
  • 52 Week Low9.15
  • 52 Week Low Date10/30/23
  • Market Cap573.84M
  • Shares Out9.27M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta2.28
  • YTD % Change27

RATIOS/PROFITABILITY

  • EPS (TTM)-68.38
  • P/E (TTM)-0.91
  • Fwd P/E (NTM)-5.95
  • EBITDA (TTM)-80.904M
  • ROE (TTM)-67.90%
  • Revenue (TTM)-
  • Gross Margin (TTM)31.89%
  • Net Margin (TTM)-931.26%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/10/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Korro Bio Inc

 

Profile

MORE
Korro Bio, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic...
Nessan Bermingham Ph.D.
Chairman of the Board, Co-Founder
Ram Aiyar Ph.D.
President, Chief Executive Officer, Director
Todd Chappell
Chief Operating Officer
Vineet Agarwal
Chief Financial Officer, Principal Accounting Officer, Treasurer, Principal Financial Officer
Address
One Kendall Square. Building 600-700
Suite 6-401
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
MLYS
Mineralys Therapeutics Inc
13.05+0.25+1.95%
COGT
Cogent Biosciences Inc
7.24+0.31+4.47%
PHAT
Phathom Pharmaceuticals Inc
9.57+0.31+3.35%
SVRA
Savara Inc
4.76-0.19-3.74%
OLMA
Olema Pharmaceuticals Inc
10.23-0.17-1.63%